This was the stock's second consecutive day of losses.

Novo Nordisk shares dropped due to CagriSema trial results but have long-term upside. Learn why NVO stock is a Strong Buy ...

Eli Lilly continues to see strong growth coming from its GLP-1 drugs. The company's current 2025 guidance looks conservative.

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

Truist Financial analyst Srikripa Devarakonda maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) today and set a price ...

February 11, 2025, 06:09 AM ET, BY Christie, Contributor | Editor: Derek Curry ( Follow on LinkedIn ) ...

Finding stocks with the potential to double in just three years is no easy feat, even in this bull market. Plenty of ...

Eli Lilly (LLY) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of ...

According to Benzinga Pro, Eli Lilly's peer group average for short interest as a percentage of float is 4.12%, which means ...

Weight loss drugs are huge these days, and Eli Lilly (LLY) is leading the pack when it comes to these. However, today’s ...

Real-time index price for TSX 60 ESG Index (TSXE), along with buy or sell indicators, analysis, charts, historical performance, news and more ...